DE VERNEUIL VANINA (EVP, General Counsel, Corp Sec) sold 8.5% of their position (7.37K shares) of VIR BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $67.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/27/2025ACC: 0001628280-25-008499
Officer· EVP, General Counsel, Corp Sec
Since Feb 2026
-7.37K
Net shares
Net seller
$67.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.37K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.37K
Price / share
$9.14
Trade value
$67.40K
% of position
8.5%
2/26/2025
86.83K→79.46K
Total
Net shares
−7.37K
Net value
-$67.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/26/2025 | S · Sale | −7.37K | $9.14 | $67.40K | 8.5% | 86.83K | 79.46K |
| Total | −7.37K | -$67.40K | ||||||
Derivative Transactions0
No derivative transactions reported